ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,446.00
      2.17%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      82.765
      0.00%
      Bitcoin
      63,825.51
      1.49%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Oric Pharmaceuticals Inc (ORIC)

      7. Oric Pharmaceuticals Inc (ORIC) News

      ORIC

      Oric Pharmaceuticals (ORIC)

      Oric Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ORIC
      DateTimeSourceHeadlineSymbolCompany
      05/03/20244:30PMGlobeNewswire Inc.ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ORICOric Pharmaceuticals Inc
      04/15/20244:15PMGlobeNewswire Inc.ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLCNASDAQ:ORICOric Pharmaceuticals Inc
      04/08/20248:00AMGlobeNewswire Inc.ORIC Pharmaceuticals Presents Preclinical Data on Two Programs at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:ORICOric Pharmaceuticals Inc
      04/05/20244:30PMGlobeNewswire Inc.ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ORICOric Pharmaceuticals Inc
      04/04/20244:30PMGlobeNewswire Inc.ORIC Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:ORICOric Pharmaceuticals Inc
      03/11/20245:28PMEdgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:ORICOric Pharmaceuticals Inc
      03/11/20244:20PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ORICOric Pharmaceuticals Inc
      03/11/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORICOric Pharmaceuticals Inc
      03/11/20244:05PMGlobeNewswire Inc.ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational UpdatesNASDAQ:ORICOric Pharmaceuticals Inc
      03/06/20244:30PMGlobeNewswire Inc.ORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma ConferenceNASDAQ:ORICOric Pharmaceuticals Inc
      03/05/20244:30PMGlobeNewswire Inc.ORIC Pharmaceuticals Announces Multiple Presentations at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:ORICOric Pharmaceuticals Inc
      03/01/20244:30PMGlobeNewswire Inc.ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ORICOric Pharmaceuticals Inc
      02/14/20244:30PMGlobeNewswire Inc.ORIC Pharmaceuticals to Participate in the Citi 2024 Virtual Oncology Leadership SummitNASDAQ:ORICOric Pharmaceuticals Inc
      02/05/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ORICOric Pharmaceuticals Inc
      02/02/20244:30PMGlobeNewswire Inc.ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ORICOric Pharmaceuticals Inc
      01/31/20244:30PMGlobeNewswire Inc.ORIC Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:ORICOric Pharmaceuticals Inc
      01/30/202412:12PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ORICOric Pharmaceuticals Inc
      01/26/20244:58PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ORICOric Pharmaceuticals Inc
      01/25/20241:24PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ORICOric Pharmaceuticals Inc
      01/22/20249:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORICOric Pharmaceuticals Inc
      01/22/20248:30AMGlobeNewswire Inc.ORIC Pharmaceuticals Announces $125 Million Private Placement FinancingNASDAQ:ORICOric Pharmaceuticals Inc
      01/09/20249:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORICOric Pharmaceuticals Inc
      01/08/20248:30AMGlobeNewswire Inc.ORIC Pharmaceuticals Provides Initial Phase 1b Data for ORIC-944, Operational Highlights for 2023, and Anticipated Upcoming MilestonesNASDAQ:ORICOric Pharmaceuticals Inc
      01/02/20244:30PMGlobeNewswire Inc.ORIC Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ORICOric Pharmaceuticals Inc
      12/29/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ORICOric Pharmaceuticals Inc
      12/15/20234:32PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ORICOric Pharmaceuticals Inc
      12/11/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORICOric Pharmaceuticals Inc
      12/11/202312:00PMGlobeNewswire Inc.Initial Phase 1 Dose Escalation Data for ORIC-533 in Relapsed/Refractory Multiple Myeloma Demonstrates Clinical Activity and Strong Safety Profile Supporting Potential for Combination DevelopmentNASDAQ:ORICOric Pharmaceuticals Inc
      12/01/20234:30PMGlobeNewswire Inc.ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ORICOric Pharmaceuticals Inc
      11/09/20234:30PMGlobeNewswire Inc.ORIC Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:ORICOric Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:ORIC